291 related articles for article (PubMed ID: 17215360)
1. Detecting and assessing macrophages in vivo to evaluate atherosclerosis noninvasively using molecular MRI.
Amirbekian V; Lipinski MJ; Briley-Saebo KC; Amirbekian S; Aguinaldo JG; Weinreb DB; Vucic E; Frias JC; Hyafil F; Mani V; Fisher EA; Fayad ZA
Proc Natl Acad Sci U S A; 2007 Jan; 104(3):961-6. PubMed ID: 17215360
[TBL] [Abstract][Full Text] [Related]
2. MRI to detect atherosclerosis with gadolinium-containing immunomicelles targeting the macrophage scavenger receptor.
Lipinski MJ; Amirbekian V; Frias JC; Aguinaldo JG; Mani V; Briley-Saebo KC; Fuster V; Fallon JT; Fisher EA; Fayad ZA
Magn Reson Med; 2006 Sep; 56(3):601-10. PubMed ID: 16902977
[TBL] [Abstract][Full Text] [Related]
3. Molecular imaging of macrophages in atherosclerotic plaques using bimodal PEG-micelles.
Mulder WJ; Strijkers GJ; Briley-Saboe KC; Frias JC; Aguinaldo JG; Vucic E; Amirbekian V; Tang C; Chin PT; Nicolay K; Fayad ZA
Magn Reson Med; 2007 Dec; 58(6):1164-70. PubMed ID: 18046703
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic Magnetic Resonance Imaging of Atherosclerosis in Apolipoprotein E Knockout Mouse Model Using Macrophage-Targeted Gadolinium-Containing Synthetic Lipopeptide Nanoparticles.
Shen ZT; Zheng S; Gounis MJ; Sigalov AB
PLoS One; 2015; 10(11):e0143453. PubMed ID: 26569115
[TBL] [Abstract][Full Text] [Related]
5. Targeted molecular probes for imaging atherosclerotic lesions with magnetic resonance using antibodies that recognize oxidation-specific epitopes.
Briley-Saebo KC; Shaw PX; Mulder WJ; Choi SH; Vucic E; Aguinaldo JG; Witztum JL; Fuster V; Tsimikas S; Fayad ZA
Circulation; 2008 Jun; 117(25):3206-15. PubMed ID: 18541740
[TBL] [Abstract][Full Text] [Related]
6. Identifying macrophage enrichment in atherosclerotic plaques by targeting dual-modal US imaging/MRI based on biodegradable Fe-doped hollow silica nanospheres conjugated with anti-CD68 antibody.
Ji R; Li X; Zhou C; Tian Q; Li C; Xia S; Wang R; Feng Y; Zhan W
Nanoscale; 2018 Nov; 10(43):20246-20255. PubMed ID: 30361722
[TBL] [Abstract][Full Text] [Related]
7. Collagen-specific peptide conjugated HDL nanoparticles as MRI contrast agent to evaluate compositional changes in atherosclerotic plaque regression.
Chen W; Cormode DP; Vengrenyuk Y; Herranz B; Feig JE; Klink A; Mulder WJ; Fisher EA; Fayad ZA
JACC Cardiovasc Imaging; 2013 Mar; 6(3):373-84. PubMed ID: 23433925
[TBL] [Abstract][Full Text] [Related]
8. Incorporation of an apoE-derived lipopeptide in high-density lipoprotein MRI contrast agents for enhanced imaging of macrophages in atherosclerosis.
Chen W; Vucic E; Leupold E; Mulder WJ; Cormode DP; Briley-Saebo KC; Barazza A; Fisher EA; Dathe M; Fayad ZA
Contrast Media Mol Imaging; 2008; 3(6):233-42. PubMed ID: 19072768
[TBL] [Abstract][Full Text] [Related]
9. In vivo magnetic resonance imaging of atherosclerotic lesions with a newly developed Evans blue-DTPA-gadolinium contrast medium in apolipoprotein-E-deficient mice.
Yasuda S; Ikuta K; Uwatoku T; Oi K; Abe K; Hyodo F; Yoshimitsu K; Sugimura K; Utsumi H; Katayama Y; Shimokawa H
J Vasc Res; 2008; 45(2):123-8. PubMed ID: 17940339
[TBL] [Abstract][Full Text] [Related]
10. Molecular and cellular targets of the MRI contrast agent P947 for atherosclerosis imaging.
Ouimet T; Lancelot E; Hyafil F; Rienzo M; Deux F; Lemaître M; Duquesnoy S; Garot J; Roques BP; Michel JB; Corot C; Ballet S
Mol Pharm; 2012 Apr; 9(4):850-61. PubMed ID: 22352457
[TBL] [Abstract][Full Text] [Related]
11. Near-infrared fluorescence imaging of murine atherosclerosis using an oxidized low density lipoprotein-targeted fluorochrome.
Lu T; Wen S; Cui Y; Ju SH; Li KC; Teng GJ
Int J Cardiovasc Imaging; 2014 Jan; 30(1):221-31. PubMed ID: 24170262
[TBL] [Abstract][Full Text] [Related]
12. Folate receptor–targeted single-photon emission computed tomography/computed tomography to detect activated macrophages in atherosclerosis: can it distinguish vulnerable from stable atherosclerotic plaques?
Winkel LC; Groen HC; van Thiel BS; Müller C; van der Steen AF; Wentzel JJ; de Jong M; Van der Heiden K
Mol Imaging; 2014; 13():. PubMed ID: 24757762
[TBL] [Abstract][Full Text] [Related]
13. Annexin A5-functionalized bimodal nanoparticles for MRI and fluorescence imaging of atherosclerotic plaques.
van Tilborg GA; Vucic E; Strijkers GJ; Cormode DP; Mani V; Skajaa T; Reutelingsperger CP; Fayad ZA; Mulder WJ; Nicolay K
Bioconjug Chem; 2010 Oct; 21(10):1794-803. PubMed ID: 20804153
[TBL] [Abstract][Full Text] [Related]
14. In vivo detection of oxidation-specific epitopes in atherosclerotic lesions using biocompatible manganese molecular magnetic imaging probes.
Briley-Saebo KC; Nguyen TH; Saeboe AM; Cho YS; Ryu SK; Volkova ER; Dickson S; Leibundgut G; Wiesner P; Green S; Casanada F; Miller YI; Shaw W; Witztum JL; Fayad ZA; Tsimikas S
J Am Coll Cardiol; 2012 Feb; 59(6):616-26. PubMed ID: 22300697
[TBL] [Abstract][Full Text] [Related]
15. Early Assessment of Atherosclerotic Lesions and Vulnerable Plaques in vivo by Targeting Apoptotic Macrophages with AV Nanobubbles.
Ma X; Wang J; Li Z; Zhou X; Liang X; Wang J; Duan Y; Zhao P
Int J Nanomedicine; 2022; 17():4933-4946. PubMed ID: 36275481
[TBL] [Abstract][Full Text] [Related]
16. Increased neovascularization in advanced lipid-rich atherosclerotic lesions detected by gadofluorine-M-enhanced MRI: implications for plaque vulnerability.
Sirol M; Moreno PR; Purushothaman KR; Vucic E; Amirbekian V; Weinmann HJ; Muntner P; Fuster V; Fayad ZA
Circ Cardiovasc Imaging; 2009 Sep; 2(5):391-6. PubMed ID: 19808627
[TBL] [Abstract][Full Text] [Related]
17. Use of contrast enhancement and high-resolution 3D black-blood MRI to identify inflammation in atherosclerosis.
Hur J; Park J; Kim YJ; Lee HJ; Shim HS; Choe KO; Choi BW
JACC Cardiovasc Imaging; 2010 Nov; 3(11):1127-35. PubMed ID: 21071000
[TBL] [Abstract][Full Text] [Related]
18. Contrast enhancement by lipid-based MRI contrast agents in mouse atherosclerotic plaques; a longitudinal study.
den Adel B; van der Graaf LM; Que I; Strijkers GJ; Löwik CW; Poelmann RE; van der Weerd L
Contrast Media Mol Imaging; 2013; 8(1):63-71. PubMed ID: 23109394
[TBL] [Abstract][Full Text] [Related]
19. Tyrosine polyethylene glycol (PEG)-micelle magnetic resonance contrast agent for the detection of lipid rich areas in atherosclerotic plaque.
Beilvert A; Cormode DP; Chaubet F; Briley-Saebo KC; Mani V; Mulder WJ; Vucic E; Toussaint JF; Letourneur D; Fayad ZA
Magn Reson Med; 2009 Nov; 62(5):1195-201. PubMed ID: 19780153
[TBL] [Abstract][Full Text] [Related]
20. Human antibody against C domain of tenascin-C visualizes murine atherosclerotic plaques ex vivo.
von Lukowicz T; Silacci M; Wyss MT; Trachsel E; Lohmann C; Buck A; Lüscher TF; Neri D; Matter CM
J Nucl Med; 2007 Apr; 48(4):582-7. PubMed ID: 17401095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
